Fasting triglycerides and glucose index: a useful screening test for assessing insulin resistance in patients diagnosed with rheumatoid arthritis and systemic lupus erythematosus
- PMID: 31788032
- PMCID: PMC6880507
- DOI: 10.1186/s13098-019-0495-x
Fasting triglycerides and glucose index: a useful screening test for assessing insulin resistance in patients diagnosed with rheumatoid arthritis and systemic lupus erythematosus
Abstract
Background: Insulin resistance (IR) is frequently observed in patients with rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE). In clinical practice, IR assessment is limited to a low proportion of patients due to cost and equipment and technical expertise requirements. The surrogate index of triglycerides and glucose (TyG index) has been validated in non-rheumatic populations, showing adequate sensitivity and specificity for IR, although this index has not yet been used in connective tissue disorders. The aim of this study was to evaluate the frequency of insulin resistance (IR) using the validated surrogate index of triglycerides and glucose (TyG index) and to explore factors associated with IR in Mexican women with RA or SLE.
Methods: Ninety-five female RA and 57 SLE patients were included in a cross-sectional study. Clinical and epidemiological variables were evaluated. IR was assessed using the TyG index with a cutoff value of > 4.68. Logistic regression analysis was performed to identify factors associated with IR excluding confounders.
Results: IR frequency in the entire sample was 50%, higher than the 10% observed in non-rheumatic controls (p < 0.001). The frequency of IR was similar in SLE (49.1%) and RA (50.5%, p = 0.8) patients. IR was associated with a longer duration of hypertension and higher total cholesterol and low density lipoprotein cholesterol levels. Based on multivariate analysis, the duration of hypertension (OR: 1.06; 95% CI 1.002-1.12, p = 0.04), waist circumference (OR: 1.04; 95% CI 1.01-1.08, p = 0.007), uric acid levels (OR: 1.46; 95% CI 1.08-1.97, p = 0.01), RA (OR: 4.87; 95% CI 1.31-18.78, p = 0.01) and SLE (OR: 4.22; 95% CI 1.06-16.74, p = 0.04) were the main risk factors for IR.
Conclusions: This study shows that the TyG index is a useful screening test for IR in RA and SLE patients. Future longitudinal studies should be performed with the aim of identifying the predictive value of TyG index results for identifying complications linked to IR.
Keywords: Connective tissue diseases; Insulin resistance; Screening test.
© The Author(s) 2019.
Conflict of interest statement
Competing interestsThe authors declare that they have no competing interests.
Similar articles
-
Hyperleptinemia as a Marker of Various Phenotypes of Obesity and Overweight in Women with Rheumatoid Arthritis and Systemic Lupus Erythematosus.Dokl Biochem Biophys. 2024 Aug;517(1):182-194. doi: 10.1134/S1607672924700893. Epub 2024 Jun 10. Dokl Biochem Biophys. 2024. PMID: 38861143
-
Higher Prevalence and Degree of Insulin Resistance in Patients With Rheumatoid Arthritis Than in Patients With Systemic Lupus Erythematosus.J Rheumatol. 2021 Mar;48(3):339-347. doi: 10.3899/jrheum.200435. Epub 2020 Jun 15. J Rheumatol. 2021. PMID: 32541071
-
Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus.J Rheumatol. 2010 Jun;37(6):1136-42. doi: 10.3899/jrheum.090994. Epub 2010 May 1. J Rheumatol. 2010. PMID: 20436082 Free PMC article.
-
Fasting Triglycerides and Glucose Index as a Diagnostic Test for Insulin Resistance in Young Adults.Arch Med Res. 2016 Jul;47(5):382-387. doi: 10.1016/j.arcmed.2016.08.012. Arch Med Res. 2016. PMID: 27751372
-
Diagnostic Accuracy of the Triglyceride and Glucose Index for Insulin Resistance: A Systematic Review.Int J Endocrinol. 2020 Mar 10;2020:4678526. doi: 10.1155/2020/4678526. eCollection 2020. Int J Endocrinol. 2020. PMID: 32256572 Free PMC article. Review.
Cited by
-
A Systematic Review and Meta-Analysis of the Association between Uric Acid and Allantoin and Rheumatoid Arthritis.Antioxidants (Basel). 2023 Aug 5;12(8):1569. doi: 10.3390/antiox12081569. Antioxidants (Basel). 2023. PMID: 37627564 Free PMC article. Review.
-
Association between triglyceride-glucose index and subclinical carotid atherosclerosis in systemic lupus erythematosus: a cohort-based study.Front Immunol. 2025 Jun 25;16:1614970. doi: 10.3389/fimmu.2025.1614970. eCollection 2025. Front Immunol. 2025. PMID: 40636109 Free PMC article.
-
Insulin resistance in children with juvenile systemic lupus erythematosus and ınvestigation of the possibly responsible factors.Clin Rheumatol. 2022 Mar;41(3):795-801. doi: 10.1007/s10067-021-05952-9. Epub 2021 Oct 7. Clin Rheumatol. 2022. PMID: 34617197
-
Biomarkers in Systemic Lupus Erythematosus along with Metabolic Syndrome.J Clin Med. 2024 Mar 29;13(7):1988. doi: 10.3390/jcm13071988. J Clin Med. 2024. PMID: 38610754 Free PMC article. Review.
-
Study of common hypertriglyceridaemia genetic variants and subclinical atherosclerosis in a group of women with SLE and a control group.Lupus Sci Med. 2022 Aug;9(1):e000774. doi: 10.1136/lupus-2022-000774. Lupus Sci Med. 2022. PMID: 35999016 Free PMC article.
References
-
- Dougados M, Soubrier M, Antunez A, Balint P, Balsa A, Buch MH, et al. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA) Ann Rheum Dis. 2014;73:62–68. doi: 10.1136/annrheumdis-2013-204223. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources